Announcements Trials
Browse Landscape

Phase

Phase 2 2Phase NA 1Phase 4 1

Status

Completed 58Terminated 10Withdrawn 8Unknown 6Recruiting 2Active not recruiting 1

Sponsor Class

OTHER 6

Study Type

Interventional 4Observational 2

Sponsor

Cancer Type

Gastrointestinal 6

Conditions

Colorectal Neoplasms 4Recurrence 1Colorectal Cancer Metastatic 1Advanced Colorectal Cancer 1

Interventions

Cisplatin 517Radiotherapy 378Cyclophosphamide 368Carboplatin 359Capecitabine 342Paclitaxel 337Oxaliplatin 336Gemcitabine 322Docetaxel 317Fluorouracil 290Drug Therapy 276Bevacizumab 248apatinib 247camrelizumab 219Etoposide 201Irinotecan 182Doxorubicin 181Leucovorin 163Dexamethasone 161pembrolizumab 153Neoadjuvant Therapy 146sintilimab 145anlotinib 140Blood Specimen Collection 140Pemetrexed 138Cytarabine 138toripalimab 133Surgical Procedures, Operative 131Radiosurgery 131S 1 (combination) 125

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

6 trials
RecentStart dateEnrollment
Unknown × aflibercept × Clear all
NCT04810585 2021-03-23

Plasma Biomarker for Aflibercept in Advanced Colorectal Cancer

Yonsei University

Phase 4 Unknown
153 enrolled
Gastrointestinal

Recurrence, Colorectal Neoplasms

NCT04397601 2020-05-21

ARBITRATION

National Cancer Institute, Naples

Unknown
220 enrolled
Gastrointestinal

Colorectal Neoplasms

NCT04252456 2020-02-05

DISTINCTIVE

Gruppo Italiano per lo studio dei Carcinomi dell'Apparato Digerente

Phase NA Unknown
150 enrolled
Gastrointestinal

Advanced Colorectal Cancer

NCT02331927 2019-09-20

PERMAD

University of Ulm

Phase 2 Unknown
150 enrolled
Gastrointestinal

Colorectal Neoplasms

NCT03923036 2019-04-22

AVOCETTE

University Hospital, Caen

Unknown
2,000 enrolled
Gastrointestinal

Colorectal Cancer Metastatic

NCT02624726 2019-02-22

MINOAS

Hellenic Oncology Research Group

Phase 2 Unknown
31 enrolled
Gastrointestinal

Colorectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡